2018 International Congress Archives - Page 166 of 177

B lymphocytes may be protective in early Parkinson’s disease and in an animal model of dopaminergic cell death

K. Scott, C. Williams-Gray, R. Wijeyekoon, S. Hayat, K. Hall, P. Tyers, R. Mathews, R. Barker, M. Clatworthy (Cambridge, United Kingdom)
Background pathology of ‘corticobasal degeneration (CBD) mimics’ -Japanese validation study of CBD (J-VAC study)

T. Shimohata, I. Aiba, M. Yoshida, Y. Toyoshima, S. Murayama, T. Uchihara, T. Arai, Y. Saito, H. Takigawa, K. Hasegawa, T. Ikeuchi, M. Hasegawa, T. Komori, K. Wakabarashi, A. Tokumaru, K. Sakurai, K. J-VAC study (Gifu, Japan)
Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD

J. Málly (Sopron, Hungary)
Balance and gait analysis of GBA mutation carriers with Parkinson’s disease (PD)

A. Gera, J. Okeefe, N. Purcell, C. Huml, S. Ruehl, B. Ouyang, G. Pal (Chicago, IL, USA)
Ballism as major manifestation in Neuroleptic Malignant Syndrome in a patient toxoplasmosis cerebri

A. Wirathmawati, N. Raisa, B. Munir (Malang, Indonesia)
Basal Ganglionic Lesions in Egyptian Children: Radiological Findings in Correlation with Etiology and Clinical Manifestations

H. Zehry, S. Darwish, S. El zayat, H. Gad, H. Emam, M. (Mansoura, Egypt)
Baseline predictors of clinical and imaging progression in Parkinson’s disease: Results from the PPMI study

L. Chahine, A. Siderowf, C. Caspell-Garcia, J. Barnes, N. Seedorff, C. Coffey, D. Galasko, B. Mollenhauer, V. Arnedo, N. Daegele, M. Frasier, C. Tanner, K. Kieburtz, K. Marek (Pittsburgh, PA, USA)
Bdnf rs6265 and Other Variants Predict the Efficacy of Levodopa Monotherapy in Early-Stage Parkinson’s Disease

C. Sortwell, P. Auinger, J. Goudreau, B. Pickut, M. Hacker, P. Charles, J. Lipton, A. Cole-Strauss, J. Elm, D. Fischer (Grand Rapids, MI, USA)
BDNF(V66M), EIF4G1(R1205H), VPS35(D620N) gene polymorphisms in South Indian PD Patients

T. Syed, T. S.D, S. Meka, S. Kumar, S. Thandra, V. Kutala, R. Kandadai, R. Borgihain (Hyderabad, India)
Behavior and PET Imaging Study in Parkinsonian Rat Models Induced by Injection of 6-OHDA in Medial Forebrain Bundle

W. Xian, Q. Guo, L. Jiang, Z. Pei, L. Chen (Guangzhou, China)
Beneficial nonmotor effects of subthalamic and pallidal DBS in Parkinson’s disease

H. Dafsari, M. dosSantos Ghilardi, V. Visser-Vandewalle, A. Rizos, K. Ashkan, M. Silverdale, J. Evans, R. Martinez, R. Cury, M. Barbe, G. Fink, A. Antonini, K. Ray-Chaudhuri, P. Martinez-Martin, E. Fonoff, L. Timmermann (Cologne, Germany)
Benign hereditary chorea with nocturnal dyskinesias

A. Mook, C. Kilbane (Cleveland, OH, USA)
Bereitschaftspotential in a Patient with Functional Propriospinal Myoclonus

C.H. Tsai, M.K. Lu, Y.F. Chen, Y.Y. Chang, J.C. Chen (Taichung, Taiwan)
Beta burst coupling across the motor circuit in patients with Parkinson’s disease

G. Tinkhauser, F. Torrecillos, Y. Duclos, H. Tan, A. Pogosyan, P. Fischer, R. Carron, M. Welter, C. Karachi, W. Vandenberghe, B. Nuttin, T. Witjas, J. Régis, J. Azulay, A. Eusebio, P. Brown (Oxford, United Kingdom)
Bidirectional gut-to-brain and brain-to-gut propagation of α-synuclein pathology in non-human primates

ML. Arotçarena, S. Dovero, A. Prigent, M. Bourdenx, P. Aubert, I. Trigo, G. Porras, ML. Thiolat, M. Tasselli, C. Estrada, A. Recasens, J. Blesa, M. Herrero, N. Carillo, M. Vila, J. Obeso, P. Derkinderen, B. Dehay, E. Bezard (Bordeaux, France)
Bilateral Deep Brain Stimulation of the Ventral Intermediate Thalamic Nucleus for Orthostatic Tremor: A Case Report

N. Warneke, E. Wilbers, T. Warnecke, W. Stummer (Münster, Germany)
Bilateral stereotypy after unilateral cerebellar infarction

S. Choi, C. Shin, T. Ahn (Seoul, Republic of Korea)
Bilateral subthalamic deep brain stimulation combined with thalamotomy for PRRT2-associated generalized dystonia: A case report

DD. Zhang, JL. Liu, J. Yan, XJ. She, XD. Cai (Shenzhen, China)
Bio-Electro Stimulation Therapy for the Treatment of Motor and Non-Motor Symptoms in Parkinson’s Disease

T. Tsao, C. Fontana, A. Waite (Boston, MA, USA)
Biofabricated tissue constructs to recapitulate the anatomy and functionality of the nigrostriatal pathway in Parkinson’s disease

J. Duda, L. Struzyna, K. Browne, H. Chen, D. Cullen (Philadelphia, PA, USA)
Biological course and natural history of hereditary spastic paraplegia type 11 (SPG11)

T. Musacchio, K. Nohl, K. Boelmans, V. Maltese, D. Zeller, I. Isaias, J. Volkmann, S. Klebe (Würzburg, Germany)
Biomarkers of rapid progression of cognitive decline in Parkinson’s disease

S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, J. Marin-Lahoz, A. Horta-Barba, H. Bejr-Kasem, I. Aracil, J. Perez-Perez, MA. Boti, J. Kulisevsky. (Barcelona, Spain)
Bipolar directional DBS in VIM-stimulated patients

J. Steffen, P. Reker, F. Mennicken, T. Dembek, H. Dafsari, G. Fink, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)
Blinded acute assessment of electrode contact efficacy compared with contact location for Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

G. Lim, B. Jonker, S. Bolitho, S. Tisch (Sydney, Australia)
Blink Recovery Pattern and Somatosensory Evoked Blink Reflex in patients with Parkinsonism syndromes

S. Tandra, R.M. Mridula, R. Borgohain (Hyderabad, India)
Blockade D1-like and D2-like dopamine receptors within nucleus accumbens attenuate hyperalgesia responses in a 6-OHDA induced parkinson’s disease rat model

L. Li, CJ. Mao, XQ. Zhang, F. Wang, CF. Liu (Su Zhou, China)
Bmal1 deficiency aggravates MPTP-induced dopaminergic cell death through promoting neuroinflammation

C. Gu, W. Liu, X. Gu, F. Wang, Y. Yang, C. Liu (Su Zhou, China)
Body concept and quality of life in patients with idiopathic dystonia

L. Paracka, F. Wegner, C. Escher, M. Klietz, M. Abdallat, J. Krauss (Hannover, Germany)
Bone health and laboratorial correlations of Vitamin D in Parkinson’s disease

L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)
Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy

A. Lozza, A. Castagna, G. Castelnovo, E. Alfonsi, A. Montini, L. Marchetta, M. Fresia, A. Arrigo, R. Manni (Pavia, Italy)
Botulinum toxin A injection for treatment of adductor spasmodic dysphonia under guidance of fiber laryngoscope combined with needle electromyography: 2 case reports

X. Zhang, Z. Zhang, Y. Pan, L. Jin (Shanghai, China)
Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach

S. Mittal, D. Machado, D. Richardson, D. Dubey, B. Jabbari (Bangalore, India)
Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)
Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)
Botulinum toxin injections improve daily life activities in patients with upper limb tremor

A. Kreisler, B. Bouchain, L. Defebvre (Lille, France)
Botulinum Toxin Injections in Upper Limb Tremor

W. Fung, M. Ligtermoet, K. Bertram, D. Williams, J. Kamel (Melbourne, Australia)
Bradykinesia assessment using evolutionary algorithms in Parkinson’s disease: Clinical validation

C. Gao, S. Smith, M. Lones, S. Jamieson, J. Alty, J. Cosgrove, P. Zhang, J. Liu, Y. Chen, J. Du, S. Cui, H. Zhou, S. Chen (Shanghai, China)
Brain Mechanisms of Associative Memory Deficits in Parkinson’s Disease without Dementia

T. Alrazi, J. Cheetham, L. Derwent, A. Hanganu, T. Hammer, I. Kathol, M. Kibreab, S. Lang, N. Ouellet, J. Provost, M. Ramezani, J. Sarna, E. Yoon, O. Monchi (Calgary, AB, Canada)
Brain network activation (BNA): A new biomarker for Parkinson’s disease?

S. Hassin-Baer, Z. Pereman, R. Yahav, S. Israeli-Korn, G. Yahalom, S. Benizri, R. Shani-Hershkovich, G. Issachar, A. Geva, O. Cohen (Ramat Gan, Israel)
Brain Network Connectivity Measured by Diffusion Tensor Imaging Predicts Prognosis in Parkinson’s Disease

S.M. Fereshtehnejad, N. Abbasi, Y. Zeighami, K. Larcher, R. Postuma, A. Dagher (Montreal, QC, Canada)
Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study

Y. Xing, S. Naidu, S. Schwarz, N. Bajaj, D. Auer (Nottingham, United Kingdom)
Brain responses evoked by thalamic and subthalamic deep brain stimulation

J. Hirschmann, C. Hartmann, J. Vesper, L. Wojtecki, M. Butz, A. Schnitzler (Düsseldorf, Germany)
Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment

M. Park, D. Kwon (Ansan-city, Korea)
Broad White Matter Impairment in Multiple System Atrophy: A case for Oligodendrocyte Dysfunction

N. del Campo, O. Phillips, F. Ory-Magne, M. Galitzky, C. Brefel-Coubron, C. Thalamas, K. Narr, S. Joshi, M. Singh, P. Péran, A. Pavy-LeTraon, O. Rascol (Toulouse, France)
Bupropion causing misdiagnosis in brain dopamine transporter imaging for parkinsonism

E. Honkanen, N. Kemppainen, T. Noponen, M. Seppänen, J. Joutsa, V. Kaasinen (Turku, Finland)
Burden among Patients with Progressive Supranuclear Palsy

T. Xie, X. Ye, L. Kandukuri, Y. Bao (Chicago, IL, USA)
Burden of Eye disease in Parkinson’s disease (PD)

N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)
Burden of progressive supranuclear palsy: A systematic literature review

S. Chen, I. Jakab, T. Zelei, L. Szilberhorn, R. Bendes, B. Elezbawy, Z. Kaló, M. Mann, M. Potashman, J. Pitter (Cambridge, MA, USA)